Navigation Links
Heptares to Present at the 6th Annual European Life Sciences CEO Forum (5-6 March)
Date:3/1/2013

WELWYN GARDEN CITY, England and BOSTON, March 1, 2013 /PRNewswire/ --

Heptares Therapeutics, the leading GPCR drug discovery company, announces that Malcolm Weir (Heptares CEO) will attend the 6th Annual European Life Science CEO Forum  taking place on the at the Hilton Zurich Airport Hotel, Zurich, Switzerland (5-6 March), at which he will participate in a panel discussion on Platform Technologies and Novel Therapeutics (2:00pm-3:15pm, 5 March). Dr Weir will also present an overview of the company at the event (5 March, 11:45am in Panorama B).

Dr Weir and Barry Kenny (Chief Business Officer) will also attend BIO-Europe Spring 2013 at the CCIB Convention Centre, Barcelona, Spain (11-13 March).

For a full list of events at which Heptares will be present, please visit http://www.heptares.com

About Heptares Therapeutics

Heptares creates new medicines targeting clinically important, yet historically challenging, GPCRs (G protein-coupled receptors), a superfamily of drug receptors linked to a wide range of human diseases. Leveraging our advanced structure-based drug design technology platform, we have built an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including Alzheimer's disease, Parkinson's disease, schizophrenia, migraine and diabetes. Our pharmaceutical partners include Shire, Cubist, Takeda, MorphoSys, AstraZeneca and MedImmune, and we are backed by MVM Life Science Partners, Clarus Ventures, Novartis Venture Fund and Takeda Ventures. To learn more about Heptares, please vi
'/>"/>

SOURCE Heptares Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Heptares and UK Medical Research Council Extend GPCR Collaboration
2. Heptares to Present at 5th CNS Partnering and Deal-Making Conference (13-14 SEPTEMBER)
3. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
4. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
7. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
9. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
10. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
11. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... and NEW YORK , June 18, 2013 ... BDX ) are accelerating the development of new ... technologies through a new collaboration announced today. This new, three-year ... type 1 diabetes (T1D). Many patients with T1D ... requiring a catheter to be placed in the body for ...
(Date:6/18/2013)... -- Healthgrades, the leading online resource that helps consumers ... hospitals, today issued the Healthgrades Women,s Health ... to Get Your Best Outcome . The report, which ... gynecologic surgery, as well as hospitals that excelled ... the most common hospital-based conditions and procedures, urges ...
(Date:6/18/2013)... Apama Medical, a privately held medical ... atrial fibrillation technologies, today announced the issuance of ... and Trademark Office (USPTO), titled "Low Profile Electrodes". ... use on expandable structures such as balloons used ... "We are grateful to the NSF SBIR ...
Breaking Medicine Technology:JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 2JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 4
... CID s.r.l., a European company leader in interventional medicine, ... revolutionary drug eluting stent technology during The Drug Eluting ... Wednesday, September 22, 2010.  The lecture, entitled "Status of ... by Alexandre Abizaid, MD, PhD. Chief of Intervention at ...
... pleased to announce the addition of Kenneth ... to further the advancement of the group,s minimally invasive ... neurostimulators . Dr. Alo will serve as Director of ... graduated from Texas A&M University College of Medicine and ...
Cached Medicine Technology:CID to Update Interventional Cardiologists on Their Drug Eluting Stent Program at TCT 2010 2Kenneth Alo, M.D., Joins Ascendant Neuro as Director of Neuromodulation and Clinical Research 2Kenneth Alo, M.D., Joins Ascendant Neuro as Director of Neuromodulation and Clinical Research 3
(Date:6/18/2013)... Center clinical researchers have launched an innovative clinical ... the ability of a patient,s own stem cells ... arterial disease (PAD). , Led by Vik ... Hospitals Case Medical Center,s Harrington Heart & Vascular ... Reserve University School of Medicine, the clinical trial ...
(Date:6/18/2013)... 2013 The July 2013 issue of Marie ... Getting Beach Ready,” offers a list of home and doctor’s ... in a bathing suit this summer. The list includes treatment ... smoothing cellulite , and more. (go to goo.gl/aIe4J). , ... of Epione Beverly Hills, “though I would say some of ...
(Date:6/18/2013)... Atlanta (PRWEB) June 18, 2013 ... Cypress Care, ScripNet and Procura Management, today announced ... of chief sales officer. In this position, Leonardo ... support of the company’s strategic growth initiatives. , ... his leadership and expertise, Leonardo brings more than ...
(Date:6/18/2013)... 18, 2013 David Connett, DO, vice ... Medicine for the College of Osteopathic Medicine of the ... been elected president of the Osteopathic Medical Board ... Jr. appointed Connett, a 1984 alumnus of COMP, to ... elected Connett to the position during a conference call. ...
(Date:6/18/2013)... in the mammary gland appear to provide a crucial ... life, and the subsequent development of breast cancer, researchers ... 2013 issue of the journal Cancer Prevention Research ... associated with an increased risk of certain types of ... of social stress to cancer have been hard to ...
Breaking Medicine News(10 mins):Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Skin Care – Getting Your Body Beach Ready 2Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4
... replacement therapy (HRT) may increase the risk of developing asthma ... of print in the journal Thorax . The ... quizzed about their use of HRT and development of asthma ... the women were taking part in the French E3N study, ...
... ... capture the authentic heartbeat of NY Jets Quarterback Mark Sanchez for a CBS Cares public ... is a favorite in broadcasting - this may be the biggest audience to hear the ... ...
... ... The inaugural meeting of The Global Leaders, a networking group of influential ... prestigious Yale Club in New York City on February 9th. There are ... companies, with more than $700 billion in annual revenue, $5 trillion in ...
... ... provider of trace level detection technologies based on the exploitation of Surface-Enhanced ... it has appointed David Burns as its new Chief Executive Officer. He ... diagnostic (IVD) products, with the aim to establish D3 Technologies as a ...
... to take steps to prevent illness , SATURDAY, Feb. 6 ... Vancouver can be champions of their health by following some ... the U.S. Centers for Disease Control and Prevention. , The ... by remembering to "Stop, Wash and Go:" , Stop. ...
... ... the St. Louis Jewish Community Center , ... St. Louis, MO (PRWEB) February 7, 2010 -- The Museum of ImaJewnation will ... located inside the St. Louis Jewish Community Center, Staenberg Family Complex Arts & Education Building ...
Cached Medicine News:Health News:Estrogen-only HRT may increase risk of asthma after menopause 2Health News:Superbowl Heartbeat from Thinklabs Electronic Stethoscope 2Health News:Global Leaders Hold Inaugural Meeting in New York City on February 9, 2010 2Health News:Ground Breaking Molecular Diagnostics Business Appoints New CEO 2Health News:Ground Breaking Molecular Diagnostics Business Appoints New CEO 3Health News:Spectators Need to Prepare for Olympic Games, Too 2
... catheters are designed using established technology ... following benefits:, ,Working with pH ... where the multi-use catheter is used ... contact to the skin.,NOTE: ,Medtronic pH ...
... Slimline single-use pH catheters are ... cross-contamination and allow greater patient comfort ... ,Medtronic pH measurement systems have been ... that allow an accurate room-temperature calibration. ...
The WaveMax is one of the most flexible stainless steel stents due to its unique wave design and has the lowest effective profile, accommodating a 6F sheath up to 7 mm....
... the world of online quality control ... control information and peer group statistics ... introduces a revolutionary internet based format ... Why rely on traditional quality control ...
Medicine Products: